KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Cost of Revenue (2016 - 2025)

Pfizer (PFE) has disclosed Cost of Revenue for 17 consecutive years, with $5.3 billion as the latest value for Q4 2025.

  • Quarterly Cost of Revenue changed N/A to $5.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.1 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $16.1 billion for FY2025, 9.99% down from the prior year.
  • Cost of Revenue for Q4 2025 was $5.3 billion at Pfizer, up from $4.2 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $10.0 billion in Q2 2022, with the low at $2.8 billion in Q1 2025.
  • Average Cost of Revenue over 5 years is $5.8 billion, with a median of $5.3 billion recorded in 2024.
  • The sharpest move saw Cost of Revenue surged 394.87% in 2021, then tumbled 62.57% in 2023.
  • Over 5 years, Cost of Revenue stood at $9.9 billion in 2021, then plummeted by 38.95% to $6.1 billion in 2022, then rose by 24.74% to $7.6 billion in 2023, then crashed by 30.41% to $5.3 billion in 2024, then grew by 0.17% to $5.3 billion in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $5.3 billion, $4.2 billion, and $3.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.